Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder
Florence Lévy · Pharmacogenomics and Personalized Medicine · 2014
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Pharmacogenomics and Personalized Medicine · Dove Medical Press · review · 2014
Abstract
This review examines molecular genetic studies shown to be of importance in the etiology of attention-deficit/hyperactivity disorder (ADHD) and contrasts prefrontal versus sub-cortical mechanisms. Although these mechanisms are not completely dissociated, an understanding of prefrontal dopaminergic/noradrenergic versus subcortical D1/D2 receptor mechanisms is useful for studies of diagnosis versus potential adverse effects. Dopamine physiology, dopamine receptor studies, alpha-2 agonist studies, and dopamine transporter and potential new therapies are reviewed.
Further understandings of molecular mechanisms involved in etiology versus treatment and adverse effects should help personalize the treatment of ADHD.
Open the resolved locator · 10.2147/pgpm.s52844
Metadata licence: OpenAlex metadata (CC0)